Physiomics Share News (PYC)

Physiomics Information

Buy PYC Shares
Add PYC to Watchlist
Add PYC to Alert

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.30

Bid: 1.20

Ask: 1.40

Change: 0.00 (0.00%)

Spread: 0.20 (16.667%)

Open: 1.30

High: 1.30

Low: 1.30

Prev. Close: 1.30

Last checked at -

Physiomics awarded further contracts with Merck

Fri, 22nd Oct 2021 09:13

(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it had been awarded two further contracts by existing client Merck.
Physiomics said the contracts, expected to be completed by the end of 2021, involved simulations of the clinical efficacy of drug products in Merck's DNA damage/repair portfolio.

Chief executive Dr Jim Millen said: "Merck remains a key, valued client and we are pleased to be continuing to work with them on a number of important development programs."

As of 0910 BST, Physiomics shares were down 0.66 at 6.06p.

More News

12 Nov 2014 12:02

UK WINNERS & LOSERS: G4S And Tullow Oil Lead FTSE 100 Gainers

12 Nov 2014 10:47

Physiomics Optimistic On Virtual Tumour Platform Interest

4 Nov 2014 12:10

UK MIDDAY BRIEFING: Oil Stocks Down As Oil Price Hits 4-Year Low

4 Nov 2014 11:32

UK WINNERS & LOSERS: Imperial Tobacco Gains As Oil Stocks Slide

4 Nov 2014 08:27

Physiomics Shares Jump On Disclosure Of Merck As Partner

4 Nov 2014 08:21

UK MORNING BRIEFING: Legal & General, Imperial Tobacco Start Strongly

27 Oct 2014 11:11

UK WINNERS & LOSERS: Banks Under Stress After EU Test Results

27 Oct 2014 10:16

Physiomics Extends Collaboration With "Major" Pharmaceutical Company

7 Oct 2014 08:51

Physiomics Launches Web-Based Cardiac Toxicity Prediction Service

14 Aug 2014 15:41

Physiomics wins cancer therapy deal

Biology company Physiomics won a contract with an unidentified drug company on Thursday, boosting its shares by 18.75%. Under the deal, Physiomics will model immune therapy agents for cancer research by the end of the year on a fee-for-service basis. Physiomics' chief executive Mark Shadwick said:

14 Aug 2014 12:20

Physiomics Wins Contract With Undisclosed Pharmaceutical Company

12 Jun 2014 12:24

Physiomics Shares Surge On Diatech Pharmacogenetics Collaboration

LONDON (Alliance News) - Shares in Physiomics PLC surged Thursday, after it said it has signed a head of terms agreement for a new collaboration with Diatech Pharmacogenetics srl. The Oxford-based systems biology company said that, under the terms of the expected collaboration agreement, th

10 Apr 2014 12:30

UK MIDDAY BRIEFING: Same Problems For M&S, WH Smith

LONDON (Alliance News) - Retailers Marks & Spencer and WH Smith Thursday reported better performances than of late, but still saw their shares decline as analysts worried that they still have a lot to do to fix their long-standing issues.

Marks

10 Apr 2014 10:57

UK WINNERS & LOSERS: M&S, WH Smith Drop Sharply After Early Strength

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WINNERS ------- Resolution, up 1%. The firm said its insurance and pensions provider Friends Life is scrapping active member

10 Apr 2014 08:02

Physiomics To Show New Validation For Virtual Tumour Platform

LONDON (Alliance News) - Physiomics PLC said Thursday that it will be demonstrating a new validation of its Virtual Tumour Clinical Platform at a workshop in France, with a study that shows the platform can be used to make accurate predictions of clinical outcomes. The Virtual Tumour Clinic

Latest Share Chat

Physiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Physiomics awarded further contracts with Merck

Login to your account

Quickpicks are a member only feature

Login to your account